Blacks Live Longer, Not Necessarily Better, With ALS
FRIDAY, April 5, 2019 -- Black Americans with amyotrophic lateral sclerosis (ALS) tend to live longer than whites with the disease because blacks are more likely to have a procedure called a tracheostomy, a new study shows.
But that may not always be a good thing, the researchers noted.
ALS, also called Lou Gehrig's disease, is a progressive neurodegenerative disease that destroys nerve cells that control voluntary muscle movement. In the end stages of the disease, patients are totally paralyzed.
In a tracheostomy, an opening is made through the neck into the windpipe to provide ALS patients with an airway to breathe and to remove secretions from the lungs.
"Once you have a tracheostomy and a ventilator, patients can live longer, but unfortunately with this disease that is not necessarily a good thing," said study author Dr. Michael Cartwright, a professor of neurology at Wake Forest Baptist Medical Center in Winston-Salem, N.C.
Only about 2 percent of ALS patients in the United States receive a tracheostomy, the researchers said.
In this study of 49 black and 137 white ALS patients, the researchers found that three times as many black patients had a tracheostomy as white patients.
"Although we couldn't pinpoint why African Americans had more tracheostomies in our study, we do know that earlier interventions, such as breathing masks, can slow down the rate of decline and help patients deal with the disease," Cartwright said in a Wake Forest news release.
"We think it is very important for people dealing with the disease to think about their quality of life and decide what interventions are most important to them," he added.
"As doctors we can advise and help them make these decisions beforehand rather than in emergency situations, as is often the case with tracheostomies," Cartwright concluded.
The findings were published online recently in the journal Neurology.
© 2020 HealthDay. All rights reserved.
Posted: April 2019
Read this next
FRIDAY, Oct. 16, 2020 -- An experimental drug combination lengthens survival for patients with amyotrophic lateral sclerosis (ALS), new research shows. A previous clinical trial...
WEDNESDAY, Sept. 2, 2020 -- An experimental treatment may help slow the progression of the deadly brain disease amyotrophic lateral sclerosis (ALS), a new study...
FRIDAY, March 27, 2020 -- Kids and teens spend as much as five hours a day helping care for relatives with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease,...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.